Volume 26, Number 7—July 2020
Research Letter
Rhabdomyolysis as Potential Late Complication Associated with COVID-19
Table
Parameter (reference range) | Day 1 | Day 3 | Day 6 | Day 9† | Day 10 | Day 11 | Day 12‡ | Day 15 | Day 17 | Day 20 |
---|---|---|---|---|---|---|---|---|---|---|
Myoglobin (0–140 μg/L) | ND | ND | ND | >12,000 | 12,550 | 7,905 | 3,280 | 928 | 152 | 86 |
Creatine kinase (38–174 U/L) | 47 | ND | ND | 11,842 | 17,434 | 14,318 | 11,067 | 2,954 | 1,447 | 251 |
LDH (109–245 U/L) | 280 | ND | ND | 2,347 | 2,137 | 1,979 | 1,754 | 1,265 | 923 | 597 |
α-hbdh (72–182 U/L) | 277 | ND | ND | 1,612 | 1,436 | 1,171 | 1,143 | 1,037 | 911 | 189 |
Amyloid A (0–10 mg/L) | 746 | ND | ND | 429 | 192 | 105 | 126 | 93 | 84 | 25 |
CRP (0–8 mg/L) | 111 | 123 | 206 | 58 | 45 | 23.4 | 23.4 | 21.4 | 6.1 | 15 |
ALT (5–40 U/L) | 37 | 82 | 61 | 111 | 162 | 171 | 172 | 142 | 133 | 56 |
AST (8–40 U/L) | 48 | 88 | 35 | 213 | 373 | 348 | 320 | 183 | 135 | 38 |
Albumin (35–55 g/L) | 33.7 | 31.8 | 27.6 | 32.3 | 28.5 | 30.3 | 30 | 30.7 | 29.3 | 30.3 |
Creatine (44–133 μmol/L) | 72.5 | 74.4 | 72.6 | 65.2 | 68.9 | 68.8 | 59.2 | 68 | 65.7 | 67.3 |
PH (7.35–7.45) | ND | ND | ND | ND | 7.51 | 7.4 | 7.48 | 7.45 | ND | 7.40 |
PCO2 (35–45 mm Hg) | ND | ND | ND | ND | 29.2 | 34.8 | 34.6 | 36 | ND | 38 |
PO2 (83–103 mm Hg) | ND | ND | ND | ND | 49 | 147 | 142 | 120 | ND | 102 |
*α-hbdh, α-hydroxybutyrate dehydrogenase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; LDH, lactate dehydrogenase; ND, not done.
†Rhabdomyolysis symptoms appeared on hospital day 9.
‡Real-time reverse transcription PCR conducted on hospital day 12 was negative for severe acute respiratory syndrome coronavirus 2.
Page created: March 20, 2020
Page updated: June 18, 2020
Page reviewed: June 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.